Hepatoblastoma: recent developments in research and treatment, Semin Pediatr Surg, vol.21, pp.21-30, 2012. ,
Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium, Mod Pathol, vol.27, pp.472-491, 2014. ,
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer, Cancer Cell, vol.14, pp.471-484, 2008. ,
Predictors of survival and incidence of hepatoblastoma in the paediatric population, HPB (Oxford), vol.15, pp.741-746, 2013. ,
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIO-PEL-4): a prospective, single-arm, feasibility study, Lancet Oncol, vol.14, pp.834-842, 2013. ,
Cardiotoxicity of anticancer treatments: epidemiology, detection, and management, CA Cancer J Clin, vol.66, pp.309-325, 2016. ,
Genotype-phenotype correlation of CTNNB1 mutations reveals different beta-catenin activity associated with liver tumor progression, Hepatology, vol.64, pp.2047-2061, 2016. ,
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas, Proc Natl Acad Sci U S A, vol.95, pp.8847-8851, 1998. ,
Wnt/beta-catenin signaling and disease, Cell, vol.149, pp.1192-1205, 2012. ,
Drugging Wnt signalling in cancer, EMBO J, vol.31, pp.2737-2746, 2012. ,
Therapeutic targeting of microRNAs: current status and future challenges, Nat Rev Drug Discov, vol.13, pp.622-638, 2014. ,
siRNA versus miRNA as therapeutics for gene silencing, Mol Ther Nucleic Acids, vol.4, p.252, 2015. ,
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer, Proc Natl Acad Sci U S A, vol.107, pp.20471-20476, 2010. ,
Altered microRNA expression patterns in hepatoblastoma patients, Transl Oncol, vol.2, pp.157-163, 2009. ,
MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma, Hepatology, vol.53, pp.833-842, 2011. ,
Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/ beta-catenin signaling pathway, Mol Cell Biol, vol.29, pp.5923-5940, 2009. ,
p53 and microRNA-34 are suppressors of canonical Wnt signaling, Sci Signal, vol.4, p.71, 2011. ,
Mutated beta-catenin evades a microRNA-dependent regulatory loop, Proc Natl Acad Sci U S A, vol.108, pp.4840-4845, 2011. ,
MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin, Biochem Biophys Res Commun, vol.428, pp.525-531, 2012. ,
A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma, Hepatology, vol.57, pp.195-204, 2013. ,
Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method, Mol Cell Proteomics, vol.8, pp.1777-1788, 2009. ,
Molecular basis of differential target regulation by miR-96 and miR-182: the glypican-3 as a model, Nucleic Acids Res, vol.40, pp.1356-1365, 2012. ,
Antitumour activity of an inhibitor of miR-34a in liver cancer with beta-catenin-mutations, Gut, vol.65, pp.1024-1034, 2016. ,
AU-rich elements and alternative splicing in the beta-catenin 3 0 UTR can influence the human beta-catenin mRNA stability, Exp Cell Res, vol.312, pp.2367-2378, 2006. ,
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice, J Hepatol, vol.45, pp.377-386, 2006. ,
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer, Mol Cell, vol.49, pp.80-93, 2013. ,
Accessing key steps of human tumor progression in vivo by using an avian embryo model, Proc Natl Acad Sci U S A, vol.102, pp.1643-1648, 2005. ,
Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells, Gastroenterology, vol.138, pp.1591-1598, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00505056
A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis, Oncogene, vol.34, pp.1094-1104, 2015. ,
p53-dependent induction of PVT1 and miR-1204, J Biol Chem, vol.287, pp.2509-2519, 2012. ,
MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival, Cell Death Differ, vol.18, pp.974-984, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00608714
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer, Mol Cancer, vol.10, p.29, 2011. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011. ,
beta-catenin mediates stress resilience through Dicer1/microRNA regulation, Nature, vol.516, pp.51-55, 2014. ,
miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A, Genes Dev, vol.23, pp.2388-2393, 2009. ,
Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression, Eur J Gynaecol Oncol, vol.35, pp.688-691, 2014. ,
Clinical experiences with systemically administered siRNA-based therapeutics in cancer, Nat Rev Drug Discov, vol.14, pp.843-856, 2015. ,